A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition | npj Precision Oncology
商品説明・詳細
送料・お届け
商品情報
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition | npj Precision Oncology,Frontiers | Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology,Single-bed, whole-body 68Ga DOTATATE PET/CT delineation of neuroendocrine tumor metastases,Integrated multi-omics analysis of zinc-finger proteins uncovers roles in RNA regulation: Molecular Cell,Traumatic giant cell tumor of rib: A case report